This Fox Chase professor participates in the Undergraduate Summer Research Fellowship.
Learn more about Research Volunteering.
Chair, Department of Clinical Genetics
Professor, Department of Clinical Genetics
Director, Gastrointestinal Risk Assessment
Co-Leader, Cancer Prevention and Control Program
NCCN, Genetic Colorectal/Colorectal Cancer Screening Panel Member
Liver, Gall Bladder & Bile Duct Cancer, Pancreatic Cancer, Esophageal Cancer, Neuroendocrine Tumors, Colorectal Cancer, Stomach (Gastric) Cancer, Appendix Cancer
I am a GI oncologist and a clinical cancer geneticist, and I have found over the years that my strongest skills are in helping my patients and their families to understand the complicated risks of cancer screening, surgery and treatment, to weigh the different options for treatment, and finally to develop a plan that is both in line with cutting edge research but also with their personal needs and preferences for their health and their lives. In cancer medicine, there is no longer a one size fits all approach, and in my practice I strive to build on my patients’ unique strengths and to further bring the multi-faceted expertise of my colleagues at Fox Chase and my colleagues nationally to offer each of my patients the best care I possibly can.
Since 1991, the Risk Assessment Program has received strong support from its clinical and research participants and referring providers. Over 11,000 patients have joined RAP’s registry and donated epidemiologic data and a biospecimen (~8,000 blood donations). This valuable resource is available to FCCC investigators and the wider genetics community and has generated significant grant support, publications, and presentations at national/international venues. RAP, the research component of the Department of Clinical Genetics, is part of the FCCC Cancer Prevention and Control (CPC) program. RAP maintains close collaborations with clinical, behavioral, and laboratory scientists with research interests in genetic risk and cancer prevention. RAP administers studies of the biological, genetic and environmental factors that influence cancer risk. RAP has established a unique registry of family data, blood, and tissue samples that is used to study the genetic basis of cancer. Our work is supported by funding from governmental, foundation, industry, and philanthropic sources and has contributed significantly to the field.
My group’s research is in three areas related to GI genetic risk and risk assessment. My primary syndrome of expertise and study is Lynch syndrome, but I have also performed research among all high risk GI patients, patients with hereditary breast/ovarian cancer and BRCA1/2 mutations, hereditary pancreatic cancer, high risk renal cell cancers, and others:
This Fox Chase professor participates in the Undergraduate Summer Research Fellowship.
Learn more about Research Volunteering.
Patient comments
They listen, they care and they know their business. I can't ask for anything more.
Dr. Hall suggested the next line of treatment along with his reasoning.
After the telehealth with Dr. Hall I felt better because he discussed my treatment options with care and compassion.
I want to say that all staff, nurses, doctors etc were very professional. Each had the best bedside manner. I always feel as I'm treated as a person and not just a number.
I have been very happy with all of my Temple doctors.